infectious diseases Archives
New space bolsters infectious disease and immunology discovery
Jul. 9, 2020—The Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) recently moved into its new research and administrative home.
Five things to know about China’s coronavirus outbreak
Feb. 5, 2020—Vanderbilt infectious diseases specialist Thomas Talbot, MD, MPH, answers questions about the current novel coronavirus outbreak in China.
Edwards receives American Pediatric Society’s top award
Nov. 14, 2019—Vanderbilt's Kathryn Edwards, MD, is the recipient of the 2020 John Howland Award, the highest honor given by the American Pediatric Society (APS).
RSV transmission in the Middle East
Nov. 14, 2019—Understanding how RSV is transmitted, which strains dominate and how new strains emerge around the globe will guide better vaccine and anti-viral drug design.
New test assists physicians with quicker treatment decisions for sepsis
Oct. 3, 2019—Rapid blood culture diagnostics for patients with bacterial bloodstream infections delivered final results in 12 hours versus the two to three days required for conventional testing.
New histoplasmosis risk map
Sep. 14, 2018—The new mapping approach, called suitability score mapping, should improve public health assessments and interventions for geographic-specific infections.
VUSM student’s research poster lauded at international meeting
Aug. 4, 2016—A Vanderbilt University School of Medicine (VUSM) student recently received international recognition when his poster presentation at a major infectious diseases conference was voted the best from among 600 presenters and 1,500 attendees.
Wright loves her patients and their mysteries
Jul. 21, 2016—Everyone knew everyone in Patty Wright’s hometown of Scottsville, Kentucky, population 4,336.
VUMC joins Human Vaccine Project as first scientific hub
Jul. 16, 2015—Vanderbilt University Medical Center (VUMC), the Human Vaccines Project and the International AIDS Vaccine Initiative (IAVI) announced this week that VUMC has become the project’s first scientific hub.
Target cell entry to halt Chikungunya virus
Apr. 28, 2014—Understanding how chikungunya virus binds to and enters cells offers a new target for antiviral medications.
Photo: Discovery Lecture
Mar. 14, 2013—Scott Hultgren, Ph.D., director of the Center for Women’s Infectious Disease Research at Washington University in St. Louis, talked about improving therapies for urinary tract infections during his recent Flexner Discovery Lecture.
Host proteins can control HIV infection
Oct. 5, 2012—The protein APOBEC3G contributes to spontaneous control of HIV-1 in vivo and may provide therapeutic benefits.
